August 23, 2021
- The Hebrew University
- August 23, 2021
- 4 תגובות
Prof. Jacob Nahmias from the Hebrew University proved in a clinical trial conducted at Barzilai Hospital that the drug designed to lower blood lipids reduced the inflammation caused by the corona virus within 48 hours in severe corona patients and obviated the need for artificial respiration
- The Technion
- August 23, 2021
- No comments
Technology to improve the tracking of immune system cells is the winning project at the annual project conference of the Faculty of Biomedical Engineering at the Technion. This year, 38 projects were presented at the conference and prizes were awarded to the outstanding posters